Develops organ perfusion systems for transplanting hearts, lungs, and livers.
Jun 2026Revenue $668M/yrExpenses $587M/yr
Reached break-even Jul 2024
Figures by year
When did TransMedics Group become profitable?
Its revenue passed its expenses in Jul 2024. In the 12 months to Jun 2026, revenue was $668M and expenses $587M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $605M | $497M | $109M |
| Dec 2024 | $442M | $404M | $37.5M |
| Dec 2023 | $242M | $270M | −$28.7M |
| Dec 2022 | $93.5M | $125M | −$31.4M |
| Dec 2021 | $30.3M | $69.7M | −$39.4M |
| Dec 2020 | $25.6M | $52.0M | −$26.4M |
| Dec 2019 | $23.6M | $53.2M | −$29.6M |
| Dec 2018 | $13.0M | $33.3M | −$20.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.